Inventor
David E. Tupper
Inventor
Reading, GB
Overview
Patents· 37 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds7%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
9,296,710'Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist'20168,168,659'1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators'20127,384,934'Piperazine substituted aryl benzodiazepines'2008RE040033'Process for preparing 2-methyl-thieno-benzodiazepine'20087,303,764'2-methyl-thieno-benzodiazepine formulation'20077,214,673'Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders'20076,617,321'2-methyl-thieno-benzodiazepine formulation'20036,384,281'3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors'20026,169,084'2-methyl-thieno-benzodiazepine formulation'20016,034,078'Thienobenzodiazepine compounds'20006,008,216'Process for preparing 2-methyl-thieno-benzodiazepine'19995,817,656'Mental disorders'19985,817,657'Psychoactive substance disorders'19985,817,655'Methods of treatment using a thieno-benzodiazepine'19985,703,232'Process and solvate of 2-methyl-thieno-benzodiazepine'19975,631,250'Process and solvate of 2-methyl-thieno-benzodiazepine'19975,627,178'2-methyl-thieno-benzodiazepine'19975,605,897'2-methyl-thieno-benzodiazepine'19975,389,684'Naphthalene carboxamides'19955,338,735'Pharmaceutical compounds'19945,258,378'Pyrroloazepine compounds useful as dopaminergic agents'19935,229,382'2-methyl-thieno-benzodiazepine'19935,041,461'Organic compounds and their use as pharmaceuticals'19915,028,602'Pharmaceutical compounds'19915,021,449'Organic compounds and their use as pharmaceuticals'19915,015,656'Organic compounds and their use as pharmaceuticals'19914,963,558'Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS disorders'19904,904,653'Thieno[2,3-O]azepine compounds and CNS affecting use thereof'19904,904,686'Organic compounds and their use as pharmaceuticals'19904,720,498'2-alkyl-thioergolines and their use for treating anxiety'1988RE031194'Indolo isoquinoline compounds'19834,277,480'Tetrahydroindoloisoquinolines'19814,245,095'Indolo isoquinoline compounds'19814,172,831'Thieno-benzodiazepines'19794,115,574'Benzodiazepine derivatives'19784,115,568'Thieno[3,2-b]-[1,5]benzodiazepines'19784,061,774'Halogenated amino methyl adamantane derivatives'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977–1997Patents assigned to LILLY INDUSTRIES LTD (21)· patent assignee history
1977–1981Based in Bracknell, GB· patent location history
1988–2007Based in Reading, GB· patent location history
1991Patents assigned to LILLY SA (2)· patent assignee history
1997–2016Patents assigned to LILLY CO ELI (16)· patent assignee history
2008–2012Based in Basingstoke, GB· patent location history
2008Based in Hampshire, GB· patent location history
2012–2016Patents assigned to TUPPER DAVID EDWARD (2)· patent assignee history
2012Patents assigned to COFFEY DAVID SCOTT (1)· patent assignee history
2016Based in Berkshire, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LILLY INDUSTRIES LTD | 21 | 1977–1997 |
| LILLY CO ELI | 16 | 1997–2016 |
| LILLY SA | 2 | 1991 |
| TUPPER DAVID EDWARDself | 2 | 2012–2016 |
| COFFEY DAVID SCOTT | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Reading, GB | 24 | 1988–2007 |
| Bracknell, GB | 6 | 1977–1981 |
| Basingstoke, GB | 2 | 2008–2012 |
| Berkshire, GB | 1 | 2016 |
| Hampshire, GB | 1 | 2008 |